Person

Bridgette P. Heller

Director, Dexcom

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$761K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 12, 2026DXCMSale1,012$88.29$89K
May 12, 2026DXCMSale1,012$60.01$61K
Feb 12, 2026DXCMSale1,012$68.01$69K
Nov 12, 2025DXCMSale1,012$58.07$59K
Mar 17, 2025DXCMSale352$70.33$25K
Dec 16, 2024DXCMSale1,000$76.87$77K
Sep 16, 2024DXCMSale1,000$70.00$70K
Jun 14, 2024DXCMSale1,000$113.55$114K
Sep 12, 2023DXCMSale600$106.56$64K
Dec 15, 2020DXCMSale375$356.65$134K

SEC reporting-owner ID (CIK) 1485616 · all filings on EDGAR